Cas:252955-08-1 1-(2,4-dichlorophenyl)-2-pyridin-4-ylethanone manufacturer & supplier

Chemical Name:1-(2,4-dichlorophenyl)-2-pyridin-4-ylethanone

CAS.NO:252955-08-1

Synonyms:1-(2,4-dichlorophenyl)-2-(4-pyridyl)ethan-1-one;1-(2,4-dichlorophenyl)-2-(pyridin-4-yl)ethan-1-one;2-(PYRIDIN-4-YL)-1-(2,4-DICHLOROPHENYL)ETHANONE;1-(2,4-Dichlorophenyl)-2-(pyridin-4-yl)ethanone;Ethanone,1-(2,4-dichlorophenyl)-2-(4-pyridinyl)

Molecular Formula:C₁₃H₉Cl₂NO

Molecular Weight:266.12300

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.96000

Exact Mass:265.00600

LogP:3.81380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(2,4-dichlorophenyl)-2-(4-pyridyl)ethan-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethanone,1-(2,4-dichlorophenyl)-2-(4-pyridinyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(PYRIDIN-4-YL)-1-(2,4-DICHLOROPHENYL)ETHANONE Use and application,2-(PYRIDIN-4-YL)-1-(2,4-DICHLOROPHENYL)ETHANONE technical grade,usp/ep/jp grade.

Related News: The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. 1-(2,4-dichlorophenyl)-2-pyridin-4-ylethanone manufacturer According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 1-(2,4-dichlorophenyl)-2-pyridin-4-ylethanone supplier The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. 1-(2,4-dichlorophenyl)-2-pyridin-4-ylethanone vendor First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 1-(2,4-dichlorophenyl)-2-pyridin-4-ylethanone factory On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.